Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1958 1
1967 1
1969 1
1970 2
1973 2
1975 1
1976 1
1978 2
1979 2
1980 1
1982 1
1983 2
1984 1
1985 2
1986 1
1988 2
1996 1
2004 1
2006 1
2009 1
2014 1
2016 1
2020 1
2022 1
2023 4
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

34 results

Results by year

Filters applied: . Clear all
Page 1
DFV890: a new oral NLRP3 inhibitor-tested in an early phase 2a randomised clinical trial in patients with COVID-19 pneumonia and impaired respiratory function.
Madurka I, Vishnevsky A, Soriano JB, Gans SJ, Ore DJS, Rendon A, Ulrik CS, Bhatnagar S, Krishnamurthy S, Mc Harry K, Welte T, Fernandez AA, Mehes B, Meiser K, Gatlik E, Sommer U, Junge G, Rezende E; Study group. Madurka I, et al. Infection. 2023 Jun;51(3):641-654. doi: 10.1007/s15010-022-01904-w. Epub 2022 Sep 14. Infection. 2023. PMID: 36104613 Free PMC article. Clinical Trial.
[Possibilities of non-drug treatment for Parkinson's disease].
Pokhabov DV, Abramov VG, Pokhabov DD. Pokhabov DV, et al. Among authors: abramov vg. Zh Nevrol Psikhiatr Im S S Korsakova. 2016;116(8):22-29. doi: 10.17116/jnevro20161168122-29. Zh Nevrol Psikhiatr Im S S Korsakova. 2016. PMID: 27635607 Review. Russian.
[Botulinum toxin type A (Relatox) in the treatment of chronic migraine in adults: results of phase IIIb, randomized, one-blind, multicenter, active-controlled, parallel-group trial].
Artemenko AR, Abramov VG, Konovalova ZN, Korenko AN, Krasavina DA, Kurenkov AL, Latysheva NV, Naprienko MV, Orlova OR, Filatova EG, Shevchenko VS, Yakovleva PN. Artemenko AR, et al. Among authors: abramov vg. Zh Nevrol Psikhiatr Im S S Korsakova. 2023;123(5):89-99. doi: 10.17116/jnevro202312305189. Zh Nevrol Psikhiatr Im S S Korsakova. 2023. PMID: 37315247 Clinical Trial. Russian.
[Botulinum toxin type A (Relatox) in transition from medication overuse to non-overuse status in patients with chronic migraine: a subgroup analysis of phase IIIb randomized single-blind multicenter active-controlled parallel-group trial].
Artemenko AR, Abramov VG, Bozhenkina TV, Konovalova ZN, Korenko AN, Krasavina DA, Kurenkov AL, Latysheva NV, Naprienko MV, Orlova OR, Filatova EG, Shevchenko VS, Iakovleva PN. Artemenko AR, et al. Among authors: abramov vg. Zh Nevrol Psikhiatr Im S S Korsakova. 2023;123(11):64-74. doi: 10.17116/jnevro202312311164. Zh Nevrol Psikhiatr Im S S Korsakova. 2023. PMID: 37994890 Clinical Trial. Russian.
[Corneal nerves in keratoplasty].
ABRAMOV VG. ABRAMOV VG. Vestn Oftalmol. 1958 Sep-Oct;71(5):42-9. Vestn Oftalmol. 1958. PMID: 13603971 Russian. No abstract available.
[A use of betaserc in ataxic syndromes].
Prokopenko SV, Rudnev VA, Afanas'eva EV, Abramov VG. Prokopenko SV, et al. Among authors: abramov vg. Zh Nevrol Psikhiatr Im S S Korsakova. 2004;104(8):41-5. Zh Nevrol Psikhiatr Im S S Korsakova. 2004. PMID: 15554141 Russian.
34 results